asimadoline has been researched along with ranitidine in 1 studies
| Studies (asimadoline) | Trials (asimadoline) | Recent Studies (post-2010) (asimadoline) | Studies (ranitidine) | Trials (ranitidine) | Recent Studies (post-2010) (ranitidine) |
|---|---|---|---|---|---|
| 43 | 9 | 11 | 85 | 0 | 29 |
| Protein | Taxonomy | asimadoline (IC50) | ranitidine (IC50) |
|---|---|---|---|
| Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 0.04 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.475 | |
| Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 0.04 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 8.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
1 other study(ies) available for asimadoline and ranitidine
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |